SCHEMBL4297790

SCHEMBL4297790

CC(C(=O)OC1CCCC1)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.70
CYP2D6 P10635 5/20 0.54
CHRM2 P08172 4/20 0.54
CHRM1 P11229 4/20 0.54
LMNA P02545 3/20 0.54
CHRM4 P08173 3/20 0.54
CHRM5 P08912 3/20 0.54
CHRM3 P20309 3/20 0.54
BLM P54132 3/20 0.54
CYP1A2 P05177 3/20 0.54
THRB P10828 2/20 0.54
PMP22 Q01453 2/20 0.54
CYP2C9 P11712 2/20 0.54
HSD17B10 Q99714 2/20 0.54
MEN1 O00255 1/20 0.54
MTOR P42345 1/20 0.54
KMT2A Q03164 1/20 0.54
HTT P42858 1/20 0.52
MMP2 P08253 2/20 0.50
MMP9 P14780 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16517900 1.00 CYP19A1 (0.70) CYP19A1CYP2D6CHRM2CHRM1LMNA
SCHEMBL10901068 0.98 CYP19A1 (0.73) CYP19A1CYP2D6CHRM2CHRM1LMNA
SCHEMBL28128080 0.86 CYP19A1 (0.54) CYP19A1CYP2D6CHRM2CHRM1LMNA
SCHEMBL30578089 0.85 PTGS2 (0.65) CYP19A1CYP2D6LMNACYP1A2PMP22
SCHEMBL29055589 0.85 PTGS2 (0.65) CYP19A1CYP2D6LMNACYP1A2PMP22
SCHEMBL10527457 0.84 CYP19A1 (0.97) CYP19A1CYP2D6CYP1A2TSHR
SCHEMBL10379334 0.84 CYP19A1 (0.67) CYP19A1CYP2D6CHRM2CHRM1LMNA
Ammonia Solution, Strong SCHEMBL28229773 0.83 PTGS2 (0.62) CYP19A1CYP2D6LMNACYP1A2PMP22
SCHEMBL10379344 0.83 CYP19A1 (0.69) CYP19A1CYP2D6CHRM2CHRM1LMNA
SCHEMBL9334845 0.83 CYP19A1 (1.00) CYP19A1CYP2D6CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013172-A1 NEW ALKYL ESTERS OF CYCLIC AMINO ALCOHOLS WITH MUSCARINIC M3 RECEPTOR ANTAGONIST ACTIVITY, USEFUL FOR TREATING E.G. CHRONIC BRONCHIAL OBSTRUCTION, ASTHMA AND OVERACTIVE BLADDER AstraZeneca AB (SE) 2009-01-14 EP disclosed
WO-2007123465-A1 NEW ALKYL ESTERS OF CYCLIC AMINO ALCOHOLS WITH MUSCARINIC M3 RECEPTOR ANTAGONIST ACTIVITY, USEFUL FOR TREATING E.G. CHRONIC BRONCHIAL OBSTRUCTION, ASTHMA AND OVERACTIVE BLADDER ASTRAZENECA AB (SE) 2007-11-01 WO disclosed
EP-0925278-A1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1999-06-30 EP disclosed
WO-1998011063-A1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-03-19 WO disclosed